OTC Medicines

Select an Issue

Browse OTC Medicines Content

parents with sick children

Press Releases and Statements

Over-the-Counter Cough Medicines Will Save Consumers, U.S. Healthcare System Billions Over Next Decade

A recent study conducted by Charles River Associates, a leading global consulting firm, has quantified the savings consumers and the healthcare system receive from the over-the-counter (OTC) availability of the widely used cough suppressant dextromethorphan (DXM).

Nov 1, 2016

Man wrapped in a blanket blowing his nose.

Research Reports

Managing Access to Dextromethorphan: Cost Implications of a Potential Over-the-Counter to Prescription-Only Conversion

Government officials have tried to balance the positives of OTC access against the negatives of potential abuse. This paper aims to inform this discussion by quantifying various costs that would result if products with DXM were converted from OTC to Rx.

Oct 1, 2016

two flasks and a beaker on a table in a lab

Submission

Comments to USP: Multiple Active Ingredient Product Monographs

Letter to Drs. Femia and Santos regarding multiple active ingredient product monographs.

Sep 9, 2016

Over the Next Ten Years DXM Will Save Consumers and the Healthcare System $22-31 Billion

Infographic

Over the Next Ten Years DXM Will Save Consumers and the Healthcare System $22-31 Billion

Sep 1, 2016

hands in sterile gloves holding manufactured white tablets

Submission

Comments to FDA: Quality Attribute Considerations for Chewable Tablets

Our member companies generally support the recommendations found in the guidance but have concerns about the scope of hardness measurements and maximum break strength value.

Aug 16, 2016

FDA headquarters sign in Washington DC

Press Releases and Statements

CHPA Statement on Status of Industry Efforts to Modernize the OTC Monograph System, Including Discussions on a User Fee Program

CHPA strongly supports the OTC Monograph System, but we believe that policy reforms could make the system more flexible, responsive, and accommodating to innovation.

Jul 12, 2016

happy group of teens

Press Releases and Statements

OTC Industry Program to Reduce Teen Abuse of Cough Medicine Containing Dextromethorphan Explored in Peer-Reviewed Journal

Substance Abuse Treatment, Prevention, and Policy recently published a case study authored by CHPA about the association’s efforts to curb teen abuse of OTC cough medicine containing dextromethorphan.

Jun 27, 2016

Black teenager on their smartphone

Press Releases and Statements

CHPA Applauds Delaware Lawmakers for Age-18 Sales Law on Cough Medicine

CHPA released the following statement today in support of a Delaware law prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan (DXM) to minors.

Jun 17, 2016

FDA headquarters sign in Washington DC

Submission

Comments to FDA: OTC Monograph Reform and User Fees

While the monograph system has served our nation well, it has become cumbersome and outdated and needs to be modernized.

Jun 14, 2016

FDA headquarters sign in Washington DC

Press Releases and Statements

CHPA Statement on FDA Public Meeting on OTC Monograph User Fees

Unlike other drugs subject to user fees, nonprescription drugs under the Monograph system are not subject to FDA approval prior to marketing. Many of these ingredients have been marketed for more than 40 years, with a long history of safe use. We must define value differently than industries subject to FDA approval prior to marketing.

Jun 10, 2016

Filter Results